Aicardi–Goutières syndrome: A monogenic type I interferonopathy
Scandinavian Journal of Immunology · 2023-10 · 98 (4)
DOI: 10.1111/sji.13314 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Scandinavian Journal of Immunology, online erschienen am 29.07.2023. Verfasst von Anran Liu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, School of Basic Medical Sciences, Anhui Medical University, Hefei, China. Hauptthemen laut MEDLINE: Nervous System Malformations, Autoimmune Diseases of the Nervous System, Interferon Type I. Die Arbeit wurde bisher 72-mal zitiert (Crossref) und nennt 147 Literaturangaben. Gefördert von: Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Natural Science Foundation of Anhui Province, College Students' Innovation and Entrepreneurship Training Program-Anhui Province.
Abstract (Originalsprache)
Aicardi–Goutières syndrome (AGS) is a rare monogenic autoimmune disease that primarily affects the brains of children patients. Its main clinical features include encephalatrophy, basal ganglia calcification, leukoencephalopathy, lymphocytosis and increased interferon‐α (IFN‐α) levels in the patient's cerebrospinal fluid (CSF) and serum. AGS may be caused by mutations in any one of nine genes (TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, ADAR1, IFIH1, LSM11 and RNU7‐1) that result in accumulation of self‐nucleic acids in the cytoplasm or aberrant sensing of self‐nucleic acids. This triggers overproduction of type I interferons (IFNs) and subsequently causes AGS, the prototype of type I interferonopathies. This review describes the discovery history of AGS with various genotypes and provides the latest knowledge of clinical manifestations and causative genes of AGS. The relationship between AGS and type I interferonopathy and potential therapeutic methods for AGS are also discussed in this review.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Immunology, School of Basic Medical Sciences, Anhui Medical University, Hefei, China.
- First School of Clinical Medicine, Anhui Medical University, Hefei, China.
ORCID-Profile: Songcheng Ying
Förderung
- Inflammation and Immune Mediated Diseases Laboratory of Anhui Province
- Natural Science Foundation of Anhui Province
- College Students' Innovation and Entrepreneurship Training Program-Anhui Province
Zitieren
APA
Liu, A., & Ying, S. (2023). Aicardi–Goutières syndrome: A monogenic type I interferonopathy. Scandinavian Journal of Immunology, 98(4). https://doi.org/10.1111/sji.13314
Vancouver
Liu A, Ying S. Aicardi–Goutières syndrome: A monogenic type I interferonopathy. Scandinavian Journal of Immunology. 2023;98(4). doi:10.1111/sji.13314
BibTeX
@article{Liu2023,
author = {Liu, Anran and Ying, Songcheng},
title = {Aicardi–Goutières syndrome: A monogenic type I interferonopathy},
journal = {Scandinavian Journal of Immunology},
year = {2023},
volume = {98},
number = {4},
doi = {10.1111/sji.13314}
}
EUVIMED